Carregant...

Long-term survival rates of patients with stage IIIB and IV non-small cell lung cancer treated with cisplatin plus vinorelbine or gemcitabine

Limited data exist concerning the long-term (≥5 year) survival rates of patients with stage IIIB and IV non-small cell lung carcinoma (NSCLC) receiving chemotherapy. We aimed to determine the long-term results of cisplatin plus third-generation (vinorelbine or gemcitabine) cytotoxic chemotherapy in...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: OZKAYA, SEVKET, FINDIK, SERHAT, DIRICAN, ADEM, ATICI, ATILLA GÜVEN
Format: Artigo
Idioma:Inglês
Publicat: D.A. Spandidos 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3494120/
https://ncbi.nlm.nih.gov/pubmed/23226770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2012.714
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!